A recent analysis of the relationship between tumor immunity and the circadian clock has demonstrated that the efficacy of ICIs is changed by its administration time, with enhanced effectiveness when administered during the active phase (dark phase in mice).18, 19, 22. This evidence concerns the gene CLOCK and neoplasm.